This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Sat, 04/06/2024 - 18:32 April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heartattack or stroke within three months of a prior heartattack, according to research presented at the American College of Cardiology ’s Annual Scientific Session.
The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heartattack or stroke within three months of a prior heartattack, according to research presented at ACC.24, 24, the American College of Cardiology Annual Annual Scientific Session.
New research details the first oral drug for the treatment of a type of high cholesterol -- called Lp(a) -- that is a potentially more dangerous version of the so called 'bad' cholesterol, LDL, because it is stickier and may be more likely to cause blockages and bloodclots in your arteries.
A human's health and well-being may suffer significantly after a heartattack. It occurs when blood flow to the coronary arteries is restricted, frequently by a bloodclot, which can harm the heart muscle and result in consequences like heart disease or sudden cardiac arrest. Be still and collected.
A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heartattack, stroke and death for people with Peripheral Artery Disease (PAD).
High blood pressure puts extra strain on the heart and blood vessels, increasing the risk of heartattack, stroke, and other cardiovascular problems. Regular blood pressure checks and lifestyle modifications, such as a heart-healthy diet and exercise, are essential for managing this risk.
Introduction:Xylitol, a sugar alcohol with a global market estimated at 161,500 metric tons, has been linked to increased thrombosis and risk of stroke and heartattack. fasting blood glucose was 103 13 mg/dL, HDL cholesterol was 49 10 mg/dL, and triglycerides were 173 63 mg/dL. The mean BMI was 35.2
If the pump is unable to pump blood out (either because it is defective or because something is making it more difficult to pump blood out in some way) then less blood goes around and this can damage our vital organs and be dangerous. The plaques can damage us in 2 ways.
Have you wondered what causes a heartattack? Three coronary arteries supply blood to the heart. When one of these arteries becomes completely blocked by a bloodclot, it results in a heartattack, also known as MI (Myocardial infarction). So, how do you recognize a heartattack?
A higher CAC score indicates a higher risk of a heartattack or other cardiac events. Researchers analyzed data from 579 post-menopausal women who were taking statins to control their cholesterol and had undergone two CAC scans at least one year apart. Participants did not have heart disease at the time of the first scan.
After all, most people are convinced that a raised cholesterol level causes heart disease, and there appears to be a vast mountain of data to support this hypothesis. I have spent forty years studying this area, and I am absolutely certain that cholesterol (or LDL Low Density Lipoprotein) does not cause heart disease.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content